Standards, Guidance & Notices
Showing 1–9 of 9
CEN/
CENELEC
CENELEC
EN ISO 18562-1:2024
EN ISO 18562-1:2024 Biocompatibility evaluation of breathing gas pathways in healthcare applications – Part 1: Evaluation and testing within a risk management process
This newly established harmonized standard under EU MDR addresses biocompatibility evaluation specifically for medical devices with breathing gas pathways, such as ventilators and anesthesia delivery systems. The document provides comprehensive methodology for assessing biological safety of materials and substances in contact with respiratory gases through a risk management framework. Manufacturers should evaluate the biocompatibility potential of device materials and their extractables using appropriate biological testing and chemical analysis methods proportionate to patient exposure duration and conditions. The standard specifies evaluation strategies, test selection criteria, and acceptance criteria for breathing gas pathway components. Requirements apply to all devices intended to deliver or facilitate breathing gas therapy or anesthesia. This standard was published in the EU Official Journal via Decision 2026/193.
Published: 2026-01-28
NIST
CSWP
CSWP
CSWP 34
Mitigating Cybersecurity and Privacy Risks in Telehealth Smart Home Integration
In-patient service demands have increased during a time when patients have experienced reduced access to hospital care. Hospital-at-Home (HaH) solutions are a form of telehealth that provide an in-patient care experience in patients’ homes, offering the potential for improved outcomes. While these are desirable benefits, HaH involves privacy and cybersecurity risks by introducing hospital-grade medical or biometric devices and information systems outside the hospital’s direct control (i.e., the patient’s home). Patient homes increasingly feature Internet of Things (IoT) devices, such as voice assistants (e.g., smart speakers), as part of a broader “smart home” ecosystem. These devices may not have capabilities that support privacy and security practices and may be used as pivot points for attackers to gain access to a hospital’s information system.
This paper introduces a notional high-level smart home integration reference architecture to better un
Published: 2025-12-17
CEN/
CENELEC
CENELEC
EN ISO 10993-18:2020/A1:2023
EN ISO 10993-18:2020/A1:2023 Biological evaluation of medical devices – Part 18: Chemical characterization of medical device materials within a risk management process
This harmonized standard under EU MDR (2017/745) specifies requirements for the biological safety evaluation of medical devices by implementing chemical characterization of materials within a risk management process. The document establishes methods for analyzing and evaluating material-derived substances to ensure safety during device development phases. Manufacturers should conduct systematic chemical characterization of device materials and extract substances according to defined analytical and assessment methodologies. The standard applies to all medical devices regardless of their intended use or risk class, serving as a foundational requirement for biocompatibility evaluation. This amendment was published in the EU Official Journal via Decision 2024/815.
Published: 2024-03-06
CEN/
CENELEC
CENELEC
EN ISO 14971:2019/A11:2021
EN ISO 14971:2019/A11:2021 Medical devices – Application of risk management to medical devices
This harmonized standard under EU MDR prescribes systematic risk management processes that manufacturers must implement throughout the medical device lifecycle. The document specifies methodologies for hazard identification, risk analysis, risk evaluation, and implementation of risk control measures with verification and validation. Manufacturers should establish documented risk management files demonstrating that identified hazards have been adequately controlled and that residual risks are acceptable. The standard requires post-market surveillance planning to monitor device performance and identify emerging safety concerns. Risk management must be proportionate to the device's intended use and classification. This systematic approach serves as the foundational framework for ensuring both safety and effectiveness of medical devices. The amendment was published in the EU Official Journal via Decision 2022/757.
Published: 2022-05-11
JIS
Std
Std
TRT24971
ISO/TR 24971:2020 Medical devices - Guidance on the application of ISO 14971
This technical report provides practical guidance on developing, implementing, and maintaining medical device risk management systems in accordance with JIS T 14971:2020 and its parent standard ISO 14971:2019. Published concurrently with JIS T 14971:2020 on October 1, 2020, the document offers detailed explanations and examples to support manufacturers in applying risk management principles effectively. The guidance clarifies the relationship between ISO 14971 requirements and other standards such as IEC 62304 and IEC 62366-1, demonstrating how risk management integrates with software lifecycle and usability engineering processes. Manufacturers should consult this technical report to understand implementation best practices, including hazard analysis methodologies, risk estimation approaches, risk control strategies, and residual risk evaluation techniques. The document addresses sector-specific considerations applicable to various medical device types and provides case studies demonstrating risk management in practice. This non-normative guidance helps organizations establish robust risk management culture and documentation while ensuring compliance with both Japanese regulatory requirements and international standards.
Published: 2020-10-01
JIS
Std
Std
JIST14971
JIS T 14971:2020 Medical devices - Application of risk management to medical devices (equivalent to ISO 14971:2019)
This JIS standard specifies terminology, principles, and processes for applying risk management to medical devices, including Software as a Medical Device (SaMD) and In Vitro Diagnostic devices (IVD), corresponding to ISO 14971:2019. The 2020 revision strengthens provisions for addressing security risks and aligns terminology with JIS T 0063:2020 (vocabulary for medical device risk management). Manufacturers must establish and maintain a risk management system that identifies hazards, estimates risks, implements controls, and verifies their effectiveness throughout the device lifecycle. The standard provides a structured approach to ensure patient safety by reducing risks to acceptable levels. As the foundational risk management framework under Japanese medical device regulations, this standard works in conjunction with other lifecycle standards such as JIS T 2304 and JIS T 62366-1. The document replaced JIS T 14971:2003 and represents Japan's adoption of evolving international risk management best practices.
Published: 2020-10-01
ISO
ISO/TR 24971:2020
Medical devices — Guidance on the application of ISO 14971
Provides guidance on the application of ISO 14971:2019 for risk management of medical devices, including practical examples and clarifications.
Published: 2020-06-01
ISO
ISO 14971:2019
Medical devices — Application of risk management to medical devices
Specifies terminology, principles and a process for risk management of medical devices, including software-only medical devices.
Published: 2019-12-01
ISO
ISO/TR 80002-1:2009
Medical device software — Part 1: Guidance on the application of ISO 14971 to medical device software
Provides guidance on the application of ISO 14971 to medical device software, addressing software-specific aspects of risk management.
Published: 2009-08-01
